文献速递肺栓塞与肺血管病呼吸危重症与机械通气

TBX4突变与缺失携带者新生儿及儿童期肺动脉高压的表型特征

Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension.
PubMed 文献 · Eur Respir J · 2019-08-22

该研究评估了19例携带TBX4罕见变异(6例17q23缺失、12例可能致病突变)的肺动脉高压患儿,其中10例新生儿期表现为缺氧性呼吸衰竭和PPHN,后于婴儿期或儿童期确诊PH;3例死亡、2例需肺移植,7例肺组织学显示远端肺发育异常和肺血管重构。

要点

  • TBX4变异携带者可表现为新生儿PPHN及婴儿/儿童期PH,呈双相病程。
  • 17q23缺失携带者发育障碍比例更高,可伴骨骼、心脏等异常。
  • 肺组织学显示远端肺发育异常和肺血管重构。

核心结论

  • TBX4突变和17q23缺失构成一种新的发育性肺疾病,表现为出生时和/或婴儿及儿童期严重、常呈双相的PH。

研究设计与样本

  • 研究纳入19例携带TBX4罕见变异的PH患儿(含PPHN),评估临床资料和肺组织,变异经下一代测序和拷贝数变异阵列鉴定。

主要发现

  • 变异包括6例17q23缺失(涵盖整个TBX4位点及邻近基因)和12例可能 damaging 突变。
  • 10例婴儿表现为新生儿缺氧性呼吸衰竭和PPHN,出院后于婴儿期或儿童期诊断PH。
  • 3例死亡,2例需肺移植。
  • 相关异常包括动脉导管未闭、间隔缺损、足部异常和发育障碍,发育障碍在缺失携带者中更常见。
  • 7例婴儿肺组织学显示远端肺发育异常和肺血管重构。

临床怎么用

  • 对新生儿PPHN及婴儿/儿童期PH患儿,尤其伴骨骼、心脏异常或发育障碍时,应考虑TBX4变异检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rare variants in the T-box transcription factor 4 gene (TBX4) have recently been recognised as an emerging cause of paediatric pulmonary hypertension (PH). Their pathophysiology and contribution to persistent pulmonary hypertension in neonates (PPHN) are unknown. We sought to define the spectrum of clinical manifestations and histopathology associated with TBX4 variants in neonates and children with PH.We assessed clinical data and lung tissue in 19 children with PH, including PPHN, carrying TBX4 rare variants identified by next-generation sequencing and copy number variation arrays.Variants included six 17q23 deletions encompassing the entire TBX4 locus and neighbouring genes, and 12 likely damaging mutations. 10 infants presented with neonatal hypoxic respiratory failure and PPHN, and were subsequently discharged home. PH was diagnosed later in infancy or childhood. Three children died and two required lung transplantation. Associated anomalies included patent ductus arteriosus, septal defects, foot anomalies and developmental disability, the latter with a higher prevalence in deletion carriers. Histology in seven infants showed abnormal distal lung development and pulmonary hypertensive remodelling.TBX4 mutations and 17q23 deletions underlie a new form of developmental lung disease manifesting with severe, often biphasic PH at birth and/or later in infancy and childhood, often associated with skeletal anomalies, cardiac defects, neurodevelopmental disability and other anomalies.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Galambos C, Mullen MP, Shieh JT, et al. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension. Eur Respir J. 2019. PMID: 31151956. doi:10.1183/13993003.01965-2018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。